| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439359 | European Journal of Cancer | 2018 | 11 Pages |
Abstract
Our results indicate that histologic heterogeneity in TNBC significantly informs patient outcomes and thus, has the potential to aid in the development of optimum personalised treatments.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Matthew N. Mills, George Q. Yang, Daniel E. Oliver, Casey L. Liveringhouse, Kamran A. Ahmed, Amber G. Orman, Christine Laronga, Susan J. Hoover, Nazanin Khakpour, Ricardo L.B. Costa, Roberto Diaz,